AIRE and autoimmune polyendocrine syndrome type 1: Up to 60% of cases diagnosed with APS-1(autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy - APECED),characterized by mutations in the autoimmune regulator(AIRE) gene, will develop POI.